SMTL ID : 8alx.1

Structure of human PD-L1 in complex with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.10 Å

Oligo State

hetero-1-1-mer

Ligands

3 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 2 residues within 4Å: Chain A: G.103, A.104 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:A.104 ACT.3: 4 residues within 4Å: Chain A: E.28, A.35, Y.101, G.102 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:Y.101 ACT.4: 3 residues within 4Å: Chain A: D.105, Y.106, K.107 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Y.106 Hydrogen bonds: A:Y.106 Water bridges: A:K.107 Salt bridges: A:K.107

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 8 residues within 4Å: Chain A: I.47, I.48, Q.49, E.55, D.56, L.57, V.59, Q.60 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:Q.49, A:E.55, A:E.55 Water bridges: A:I.47, A:Q.49, A:D.56, A:D.56 GOL.5: 3 residues within 4Å: Chain A: D.44, K.45, H.61 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.44 Water bridges: A:H.61

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rodriguez, I. et al., Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies. Mol Cancer (2023)

Release Date

2023-08-16

Peptides

Programmed cell death 1 ligand 1: A
3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE, AMINOMETHYLAMIDE: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Programmed cell death 1 ligand 1

3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE, AMINOMETHYLAMIDE

Related Entries With Identical Sequence